in this issue
EnviroTech :: R&D
Bayer Reinforces R&D Despite Economic Turmoil...
10:20 AM MST | December 22, 2008 | Natasha Alperowicz in Leverkusen
Bayer intends to expand its R&D activities further, despite the financial and economic crisis, chairman and CEO Werner Wenning says. Bayer’s €2.8-billion ($3.7 billion) R&D budget this year is the biggest R&D budget in Germany’s chemical and pharmaceutical sector and accounts for about 5% of all R&D spending by German industry as a whole, Wenning told journalists at the company’s “Perspective on Innovation 2008” meeting, held recently in Leverkusen. Bayer’s pharma pipeline has 50 projects in phases I to III...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee